RSS Feed
Featured Posts

Breakthrough in understanding common childhood cancer

"A study, led by experts at Newcastle University, UK, and published today in Clinical Cancer Research, has focussed on neuroblastoma cells which circulate in the blood and spread through the bone marrow. It is the first time that circulating neuroblastoma tumour cells have been identified in this way and experts say it is possible to test the effect of newer targeted types of treatments on the circulating tumour cells without the need for an invasive biopsy." Read more: https://www.eurekalert.org/pub_releases/2019-11/nu-biu112519.php#

Pediatric cancer can affect mental health of patients’ families long after initial diagnosis, study

Parents and siblings of children with cancer can struggle with anxiety, stress and other mental health issues long after the initial cancer diagnosis, according to a new study that found elevated rates of mental health-related doctor’s visits among family members up to 20 years later. Read more: https://www.theglobeandmail.com/canada/article-pediatric-cancer-can-affect-mental-health-of-patients-families-long/

Researchers find new way to target childhood cancer

An international research effort has broken fresh ground in the race to find more effective treatments for the childhood cancer neuroblastoma, by uncovering a new and as-yet unexploited target in cancer cells that therapeutic drugs can be aimed at. Read more: https://www.sciencedaily.com/releases/2019/11/191112095750.htm

Lithium can reverse radiation damage after brain tumor treatment

Children who have received radiotherapy for a brain tumour can develop cognitive problems later in life. In their studies on mice, researchers at Karolinska Institutet have now shown that the drug lithium can help to reverse the damage caused long after it has occurred. Read more: https://eurekalert.org/pub_releases/2019-11/ki-lcr111219.php#

New molecule reduces the aggressiveness of pediatric cancer

A microRNA inhibitor identified by researchers at the FAPESP-supported Human Genome and Stem Cell Research Center reduced the sizes of aggressive tumors and improved survival in mice. Read more: https://www.eurekalert.org/pub_releases/2019-11/fda-nmr110719.php

As children, they survived cancer. They faced the fallout as adults.

About one in every 600 young adults in the U.S. — 270,000 people aged 20 to 39 — is a cancer survivor, based on federal data. For most, the transition from pediatric to adult care is full of gaps and pitfalls. Read more: https://www.inquirer.com/health/childhood-cancer-survivors-radiation-treatment-michael-schiller-20191105.html

Recent Posts
Archive
Search By Tags
Follow Us
  • Facebook Basic Square
  • Twitter Basic Square
  • YouTube Social  Icon

524 Bayfield Street North
P.O. Box 20005
Barrie, ON L4M 5E9
Canada

info@opacc.org

1-888-290-5496

  • Wix Facebook page
  • Wix Twitter page
  • Instagram Social Icon
  • LinkedIn Social Icon
  • YouTube Social  Icon